What is a fractional Chief Growth Officer? A practical guide for PE-backed B2B SaaS.

A fractional Chief Growth Officer is a senior commercial operator who joins a company part-time, typically two days a week, to own commercial strategy, partner-led growth and the design of the go-to-market motion. They sit between the CEO and sales leadership, accountable for how the business grows, not the daily running of the sales floor.

The role exists because PE-backed B2B SaaS companies hit a predictable wall. Sales-led growth gets too expensive, the partner ecosystem is broken or never built, and a permanent Chief Growth Officer is too costly, too slow to land, or premature for the stage. A fractional CGO closes the gap: senior commercial leadership without the burn of a permanent hire, deployable in weeks, accountable to outcomes within a quarter.

This guide is for PE operating partners and CEOs of PE-backed B2B SaaS companies, particularly in life sciences and healthtech, deciding whether a fractional CGO is the right move.

What a fractional CGO actually owns

Looking for a fractional CGO job description? The role owns four things, and only four. Confusion creeps in when the role is asked to own everything commercial; that is a CRO job, and a different conversation.

1. Commercial strategy and GTM motion design. Where the business plays, who it sells to, and how it goes to market. The revenue architecture, not the revenue number.
2. Partner and alliance strategy. The partner programme, including who partners with the business, on what economic terms, with what enablement, against what targets. In PE-backed B2B SaaS this is usually the most under-built lever and the one with the highest leverage. More on partner-led growth.
3. Pricing and packaging where it intersects with commercial model. Not list-price tweaks, but structural decisions about packaging, segmentation, and how the company captures value as it scales.
4. Commercial integration in M&A. When the asset is buying or being bought, the fractional CGO owns commercial diligence, integration plans, and the synthesis of two go-to-market motions.

What the role does not own: the sales number, the marketing budget, day-to-day sales management, individual deal closure, or marketing demand-gen execution. Those belong to the CRO, the CMO and the VP Sales.

The fractional CGO is the architect, not the foreman. Most PE-backed B2B SaaS businesses do not need more sales effort, they need a different commercial architecture.

What a fractional CGO is not

The role is misunderstood often enough to need a definition by exclusion.

1. Not a senior salesperson. If the business needs more pipeline closed, hire a sales leader. The fractional CGO will look expensive, slow and over-strategic if the real problem is execution capacity in the existing motion.
2. Not a fractional CRO. The CRO owns the number; the CGO owns the design and the partner-led leverage that compounds it. A CRO without a CGO will hit plan once and then fight every quarter for the same gains. A CGO without a CRO will produce a clean strategy that nobody operates.
3. Not a NED or board advisor. A NED governs and challenges from the board table. A fractional CGO operates inside the business with line responsibility for the architecture they design. More on NED roles.

When to hire a fractional CGO

Five concrete triggers, in rough order of frequency.

1. Sales-led growth alone has become too expensive. CAC payback has crept past 24 months, win rates are softening, the cost of every incremental pound of ARR is rising. The instinct is to hire more reps. The right move is to redesign the motion, and partner-led growth is the lever almost nobody pulls early enough.
2. The partner ecosystem is broken, accidental, or non-existent. The business has signed partners but they produce no revenue. There is no co-sell motion, no enablement, no deal registration, no accountability. Or worse, the partner relationships exist on slides and LinkedIn announcements but not in any pipeline.
3. Pre-PE exit window, 12 to 18 months out. The commercial story needs sharpening for a sale process. Quality of revenue, partner-sourced ARR, expansion mechanics and international optionality all need to be visible and defensible. A fractional CGO can build the commercial narrative the business will be valued against.
4. International expansion without a partner motion. Direct expansion into a new geography is slow and expensive. Most PE-backed B2B SaaS plans assume direct hires that take longer to land than the plan allows. A partner-led entry is faster and cheaper but requires deliberate design.
5. M&A integration where commercial models conflict. The acquired business prices differently, sells through different channels, or targets a different ICP. Without a senior commercial architect, the integration becomes a multi-year drag on growth.

When not to hire a fractional CGO

Three cases, all real.

1. Pre-product-market-fit. The work of a fractional CGO assumes a product the market has already validated. The right people for pre-PMF businesses are founder-led commercial, design partners, and a small number of paying customers. Hire a fractional CGO too early and the engagement burns goodwill on the wrong problem.
2. When the real gap is a missing CRO. If pipeline, forecast accuracy, deal velocity and team management are the actual issues, hire a CRO, fractional or permanent. A fractional CGO asked to do a CRO job will under-deliver against either remit.
3. When the founder is unwilling to give a senior outsider operating authority. The fractional CGO must be able to make decisions about the partner programme, GTM segmentation and commercial structure without escalating every call. If the CEO will not delegate that authority, the engagement becomes advisory in practice and a waste of money.

How a fractional CGO engagement is structured

Four engagement shapes work in practice.

1. The 90-day commercial diagnostic. Fixed-fee, deliverables-based. Output is a written commercial diagnostic, a partner-strategy recommendation and a 12-month operating plan. Best used by PE operating partners doing portfolio diagnostics, or by new CEOs in their first 100 days. £35,000 to £55,000 in the UK market.
2. The two-days-a-week ongoing engagement. The most common shape after a successful diagnostic. Three-month minimum, 30-day notice thereafter. The fractional CGO sits inside the executive team, runs the partner programme, owns the commercial architecture, and reports to the CEO with a dotted line to the chair or PE operating partner. £14,000 to £18,000 per month.
3. The board-observer-plus-operator model. Fractional CGO inside the business plus a non-voting board seat. Used where governance and operating leverage need to compound. Priced as a blend of the ongoing engagement plus a NED stipend.
4. The partner-programme build. Four to six months, blended fee, sometimes with a success-linked element tied to partner-sourced pipeline or ARR. £80,000 to £140,000 depending on scope.

Fractional CGO cost and salary in the UK in 2026

Day rate for senior-operator-grade engagements sits at £1,400 to £1,800. Fractional CGO pricing is not directly comparable to a permanent Chief Growth Officer salary, because it is structured as fees against scope rather than a fixed annual package; on a full-time-equivalent basis, the equivalent annualised cost typically lands between a senior VP and a permanent CGO base, with no benefits, equity dilution or recruitment-fee burden. Lighter advisory work is priced separately. Equity or cash-plus-equity blends are available for growth-stage assets where alignment matters more than cash. Final fees depend on scope, sector complexity, travel, and whether an equity component is in play.

How to measure a fractional CGO

Six KPIs, in rough order of importance. Anyone proposing different metrics should be asked why.

1. Pipeline mix shift. The proportion of pipeline sourced or influenced by partners over time. Trend is the metric, not a single quarter's snapshot.
2. Partner-sourced ARR. Closed-won ARR where the partner is the primary source. The headline number, and the one PE will look at in diligence.
3. Partner-influenced ARR. Closed-won ARR where the partner materially accelerated or shaped the deal but was not the source. Measured separately because it is real but easily double-counted.
4. Expansion revenue. Net dollar retention, with attention to expansion driven by partner-led use cases.
5. Time-to-first-deal-with-a-new-partner. The shortest reliable test of whether the partner programme is enabling partners or just signing them.
6. CAC payback trend. Whether the partner-led motion is bending the cost-of-acquisition curve. If it is not, the programme is not yet working.

Vanity metrics to ignore: number of partners signed, number of MOUs, number of joint marketing events, LinkedIn announcements. None of those generate revenue.

The framework is the deliverable; the numbers are the work.

Fractional CGO vs fractional CRO vs NED vs consulting firm

Four roles, four different answers to "who do I hire".

A fractional CRO owns the revenue number, manages the sales team, runs the forecast, and is accountable for closure. Best when the business needs a senior sales leader without the cost of a permanent hire.

A fractional CGO owns the commercial architecture, partner-led growth, and the design of how revenue compounds. Best when the business needs a different motion, not more of the same one.

A NED brings governance, challenge from the board table, and access to a network. Best when the board needs an independent voice and the business needs a senior introduction or two. Not an operator. More on the three jobs of a NED.

A consulting firm produces a deliverable and leaves. Best when the business needs an answer and not an operator. Most PE-backed B2B SaaS commercial problems do not stop at the deliverable.

	Fractional CGO	Fractional CRO	NED	Consulting firm
Owns	Commercial architecture & partner growth	The revenue number & sales team	Governance, challenge, network	A defined deliverable
Operating authority	Yes — inside the exec team	Yes — runs the sales org	No — board only	No — produces work, leaves
Accountable for	How revenue compounds	Closure & forecast	Board decisions & risk	Quality of the artefact
Best when	Need a different motion, not more of the same	Need senior sales leadership, fast	Board needs independent voice / network	Need an answer, not an operator
Time commitment	2 days/week ongoing or 90-day sprint	3 to 4 days/week ongoing	12 to 25 days/year	Project-bounded
Indicative cost (UK 2026)	£14k to £18k/month or £35k to £55k diagnostic	£15k to £25k/month	£30k to £75k/year	£100k to £500k+ project
Lifecycle fit	Series B to pre-exit, partner-heavy SaaS	Any stage with a sales org	Post-Series B, PE-backed, exit prep	Discrete strategic decisions
Engagement length	3 months min, often 12 to 18	3 to 12 months	2 to 4 years	6 to 16 weeks

The four can co-exist. Fractional CGO plus fractional CRO is a common, effective pairing. Fractional CGO plus NED is the model Ortent often recommends.

What to look for when hiring a fractional CGO

Seven criteria. None of them are negotiable.

1. Prior commercial scale at relevant ARR. The work between £5m and £30m ARR is structurally different from the work above £100m. Look for someone who has lived where the business is going next, not five years past it.
2. Partner programme experience that produced revenue. Slides do not count. Ask for the closed-won ARR sourced by partners under their watch and how it was measured.
3. Exit experience. PE-backed work needs someone who has been through a sale process and understands what gets diligenced and what gets discounted.
4. Sector knowledge. In life sciences and healthtech, the partner ecosystem, the regulatory posture and the buying centres are particular. In horizontal SaaS, motion design is more transferable.
5. Ability to operate, not just advise. Ask for evidence of decisions they made and owned, not frameworks they recommended.
6. Willingness to put their name to numbers. The right fractional CGO will accept a measurable outcome inside a quarter.
7. Reference customers willing to talk. Two CEOs and one PE operating partner, on the phone, no exceptions.

Red flags when hiring a fractional CGO

Five flags that should end an interview.

1. Candidates who lead with frameworks, not numbers. The framework is the deliverable; the numbers are the work.
2. No commercial proof points beyond their last full-time role. A fractional CGO with one credible engagement is a former exec moonlighting. A fractional CGO with several is an operator.
3. No partner P&L ownership. If they have never been accountable for partner-sourced revenue, they cannot run a partner programme.
4. Day rate without scope clarity. Daily fees with no defined deliverables protect the fractional, not the company.
5. Over-extended portfolio. More than three or four active engagements is a warning sign. The work needs presence; presence needs time.

Worked example: course-correcting Lumeon's commercial centre of gravity from the UK to the US

At Lumeon, a clinical pathway orchestration platform, I led the US business as President while sitting on the parent board. The commercial growth thesis required a hard reset. The UK home market was structurally difficult: dominated by the NHS, long and complex buying cycles, a conservative adoption posture, and a price ceiling well below where the unit economics worked. The choice in front of the board was binary. Keep grinding the UK, or move the centre of gravity.

The diagnosis took deep work on willingness to pay, adoption velocity, competitive intensity and buyer access across multiple options. Continental Europe was considered and rejected: each country brought its own healthcare dynamics and regulatory regime, fragmenting the addressable market and slowing every commercial conversation. Other Commonwealth markets shared too much of the NHS operating model: single-payer dominance, slow adoption, and low willingness to pay. None of them resolved the UK's structural drag. The US did, and on every dimension that mattered: bigger budgets, faster adoption, sharper competitive pressure on health systems to deploy new technology, and a buying motion that responded to peer-system reference customers rather than central commissioning.

Selecting the US was the strategic call. Building access was the operational one. Cold outreach to US health systems from London does not work. Lumeon used the TechStars / Cedars-Sinai healthcare accelerator as the access wedge. Not for the funding, but for the working relationship with a tier-one health system. That gave us the live operating environment to validate use cases against US workflows, sharpen the value proposition, and build a defensible market insertion plan.

Inside eighteen months, Lumeon had won NYC Health + Hospitals, Keck Medicine of USC, and Kaiser Permanente as customers. Three tier-one US health systems on the named-customer list, not pilot programmes. The lesson for PE-backed B2B SaaS businesses sitting in a structurally difficult home market: market choice is commercial architecture. Run the analysis honestly, pick the right wedge for access, and the named-customer roster follows.

What clients say

// COMMERCIAL LEADERSHIP ENDORSEMENT

"Andrew is one of the sharpest commercial operators I've worked with, and a charismatic leader people love to work for. He sees the GTM motion and the customer simultaneously, and he builds partner ecosystems that drive pipeline rather than just logo slides."

Rick Halton Fractional CMO and SaaS Marketeer LinkedIn →

Fractional CGO services from Ortent

Ortent Advisory is led by Andrew Wyatt, former Chief Growth Officer at Sapio Sciences and a four-time exit operator across enterprise software and telecoms (Lotus to IBM, Paragon to Phone.com, Apertio to Nokia, Clearswift to Lyceum). Ortent works with PE-backed B2B SaaS companies, with depth in life sciences and healthtech, and with the PE operating partners and chairs who back them.

Engagements start with a 30-minute intro call to test fit. If there is a match, the next step is usually a 90-day commercial diagnostic. Ongoing engagements follow only where the diagnostic surfaces a problem worth operating on. Ortent works with a small number of clients at any one time so that engagements get the presence they need.

FAQs

How is a fractional CGO different from a fractional CRO?

A fractional CRO owns the revenue number and manages the sales team. A fractional CGO owns the commercial architecture and the partner-led motion that compounds the number over time. The two roles are complementary, not interchangeable. Most PE-backed B2B SaaS businesses between £5m and £30m ARR need both. The fractional CGO comes in when the architecture, not the execution capacity, is the gap.

What does a fractional CGO cost in the UK?

Day rates for senior-operator-grade engagements sit at £1,400 to £1,800 in 2026. A fixed 90-day commercial diagnostic is typically £35,000 to £55,000. A two-days-a-week ongoing engagement runs £14,000 to £18,000 per month with a three-month minimum. A four to six month partner-programme build is £80,000 to £140,000, sometimes with a success-linked element. Equity and cash-plus-equity blends are available for growth-stage assets.

Is fractional CGO pricing comparable to a permanent CGO salary?

No, and treating it as a salary comparison usually leads to the wrong answer. Fractional CGO pricing is fees against scope, not annual base. On a full-time-equivalent basis it typically lands between a senior VP and a permanent CGO base, but with no benefits, equity dilution, recruitment fee or runway risk if the engagement ends.

How long is a typical engagement?

The most common pattern is a 90-day diagnostic followed by an ongoing two-days-a-week engagement of six to twelve months. Partner-programme builds run four to six months. Engagements are scoped to install something durable, not to embed indefinitely. The goal is to leave a working motion that the permanent team operates.

Can a fractional CGO replace a permanent hire?

Sometimes, for a defined window. Most PE-backed B2B SaaS companies between £5m and £30m ARR do not have the budget or need for a permanent CGO. A fractional engagement is the right answer for the stage. Above £40m ARR, a permanent hire becomes more defensible and the fractional CGO often helps recruit and onboard the successor.

Is a fractional CGO the right fit pre-Series B?

Almost never below Series B. Earlier-stage businesses need founder-led commercial work and design partners. The fractional CGO role assumes a validated product and a commercial motion hitting a structural ceiling. Hiring too early burns budget on the wrong problem.

How does a fractional CGO work with the existing sales leader?

The fractional CGO designs the architecture; the sales leader runs the team. The sales leader owns the number and the forecast. The fractional CGO owns the partner programme, GTM motion design and commercial structure. Strong working relationships between the two roles depend on the CEO setting the boundary clearly at the start.

Can a fractional CGO sit on the board?

Yes, as a board observer, not as a NED, while operating inside the business. Combining an operating role with full NED responsibilities creates governance conflicts. After an engagement ends, a fractional CGO sometimes converts into a NED role. That transition is normal and helpful. More on NED roles.

What sectors does a fractional CGO work best in?

PE-backed B2B SaaS, with particular depth in life sciences, healthtech and regulated verticals where partner ecosystems are complex and reference customers are scarce. Horizontal SaaS engagements are also workable, but the leverage of a fractional CGO is highest where the partner economy is dense and the buying cycle is long.

How does AI change partner-led growth in B2B SaaS?

AI changes which partners matter and how the economics work. Partners that bring AI capability layered on top of a SaaS platform create compounding value when the relationship is structured for co-growth: as the partner's AI capability matures, the platform becomes a higher-value attach point, and as the platform's customer base grows, the partner has a larger deployment surface. The fractional CGO's job is to identify which AI-led or AI-adjacent partners actually produce revenue versus which produce noise, and to design economics that reward both sides for compounding rather than one-off referral. More on partner-led growth.